Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
Irhythm Technologies (IRTC) Stock Price & Analysis
501 Followers
IRTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$70.24 - $124.12
Previous Close$98.97
Volume199.72K
Average Volume (3M)382.49K
Market Cap
$3.08B
Enterprise Value$3.07B
Total Cash (Recent Filing)$133.76M
Total Debt (Recent Filing)$129.82M
Price to Earnings (P/E)―
Beta1.26
Next Earnings
Aug 01, 2024EPS Estimate
-$0.89Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.22
Shares Outstanding31,104,883
10 Day Avg. Volume445,925
30 Day Avg. Volume382,491
Standard Deviation0.20
R-Squared0.11
Alpha0.00628
Financial Highlights & Ratios
Price to Book (P/B)15.31
Price to Sales (P/S)6.50
Price to Cash Flow (P/CF)-50.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.24
Enterprise Value/Gross Profit9.27
Enterprise Value/Ebitda-64.59
Forecast
1Y Price Target
$134.10Price Target Upside35.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Irhythm Technologies News
PremiumStock Analysis & Ideas
Oppenheimer Says These Smidcap Stocks Are Favorite Summer Picks
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe 2024 revenue guidance range was raised for the Q1 beat, moving higher on other metrics, including gross margin of 68-69%.
Operational EfficiencyThe shift of back-office resources to the Philippines is expected to drive noticeable improvement in operating expenses, with long-term benefits due to lower labor costs.
Product LaunchThe FDA overhang around Zio AT is poised to lift, setting the stage for the introduction of the next-generation product, Zio MCT, which could lead to significant market share gains.
Bears Say
Financial PerformanceSG&A spend was higher than the consensus forecast due to seasonality, impacting the lower adj. EBITDA metric.
Legal And Operational CostsElevated operating expenses are due to costs related to the DOJ subpoena and warning letter.
Product IssuesRecent reports to the FDA indicate continued problems with the 'real-time' nature of the Zio AT device.
---
Ownership Overview
3.19% Insiders
43.46% Mutual Funds
15.74% Other Institutional Investors
37.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $70.24 and its highest was $124.11 in the past 12 months.
What is Irhythm Technologies’s market cap?
Currently, no data Available
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Aug 01, 2024 which is in 11 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on May 02, 2024. The company reported -$1.47 earnings per share for the quarter, missing the consensus estimate of -$0.973 by -$0.497.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -$0.89.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 31,104,883 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$1.47 in its last earnings report, missing expectations of -$0.973. Following the earnings report the stock price went down -7.395%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Among the largest hedge funds holding Irhythm Technologies’s share is Sands Capital Management LLC. It holds Irhythm Technologies’s shares valued at 249M.
---
Irhythm Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$134.10 (35.50% Upside)
$134.10 (35.50% Upside)
Hedge Fund Trend
Decreased
By 111.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $294.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.37%
12-Months-Change
Fundamentals
Return on Equity
-83.28%
Trailing 12-Months
Asset Growth
115.73%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
---
IRTC Company Deck
---
IRTC Earnings Call
Q1 2024
0:00 / 0:00
---
IRTC Stock 12 Month Forecast
Average Price Target
$134.10
▲(35.50% Upside)
Technical Analysis
Best Analysts Covering IRTC
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
-5.96%
reiterated a buy rating 3 months ago
Copying David Rescott's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -5.96% per trade.
---